192 related articles for article (PubMed ID: 11524202)
1. Valacyclovir inhibition of recovery of ocular herpes simplex virus type 1 after experimental reactivation by laser in situ keratomileusis.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Mah FS; Fish DN; Gordon YJ
J Cataract Refract Surg; 2001 Aug; 27(8):1288-93. PubMed ID: 11524202
[TBL] [Abstract][Full Text] [Related]
2. Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy.
Dhaliwal DK; Romanowski EG; Yates KA; Barnhorst DA; Goldstein M; Deeter RG; Fish DN; Gordon YJ
Cornea; 1999 Nov; 18(6):693-9. PubMed ID: 10571301
[TBL] [Abstract][Full Text] [Related]
3. Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.
Asbell PA
Trans Am Ophthalmol Soc; 2000; 98():285-303. PubMed ID: 11190029
[TBL] [Abstract][Full Text] [Related]
4. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus.
Dhaliwal DK; Romanowski EG; Yates KA; Hu D; Goldstein M; Gordon YJ
Am J Ophthalmol; 2001 Apr; 131(4):506-7. PubMed ID: 11292417
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus keratitis after laser in situ keratomileusis.
Levy J; Lapid-Gortzak R; Klemperer I; Lifshitz T
J Refract Surg; 2005; 21(4):400-2. PubMed ID: 16128340
[TBL] [Abstract][Full Text] [Related]
6. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
[TBL] [Abstract][Full Text] [Related]
8. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
9. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic perioperative antiviral therapy for LASIK in patients with inactive herpetic keratitis.
de Rojas Silva MV; Díez-Feijóo E; Javaloy J; Sánchez-Salorio M
J Refract Surg; 2006 Apr; 22(4):404-6. PubMed ID: 16629075
[TBL] [Abstract][Full Text] [Related]
11. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
12. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
13. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
14. Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits.
Kumar M; Kaufman HE; Clement C; Bhattacharjee PS; Huq TS; Varnell ED; Thompson HW; Hill JM
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4703-6. PubMed ID: 20393107
[TBL] [Abstract][Full Text] [Related]
15. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
Beeson WH; Rachel JD
Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
[TBL] [Abstract][Full Text] [Related]
16. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
LeBlanc RA; Pesnicak L; Godleski M; Straus SE
J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
[TBL] [Abstract][Full Text] [Related]
17. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
Shimomura Y
Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.
Miserocchi E; Modorati G; Galli L; Rama P
Am J Ophthalmol; 2007 Oct; 144(4):547-51. PubMed ID: 17692271
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.
Kumar M; Hill JM; Clement C; Varnell ED; Thompson HW; Kaufman HE
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5601-8. PubMed ID: 19608530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
